Literature DB >> 10863940

Glucose transporters: structure, function and consequences of deficiency.

G K Brown1.   

Abstract

There are two mechanisms for glucose transport across cell membranes. In the intestine and renal proximal tubule, glucose is transported against a concentration gradient by a secondary active transport mechanism in which glucose is cotransported with sodium ions. In all other cells, glucose transport is mediated by one or more of the members of the closely related GLUT family of glucose transporters. The pattern of expression of the GLUT transporters in different tissues is related to the different roles of glucose metabolism in different tissues. Primary defects in glucose transport all appear to be extremely rare and not all possible deficiencies have been identified. Deficiency of the secondary active sodium/glucose transporters result in glucose/galactose malabsorption or congenital renal glycosuria. GLUT1 deficiency produces a seizure disorder with low glucose concentration in cerebrospinal fluid and GLUT2 deficiency is the basis of the Fanconi-Bickel syndrome, which resembles type I glycogen storage disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10863940     DOI: 10.1023/a:1005632012591

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  52 in total

1.  Defective glucose transport across brain tissue barriers: a newly recognized neurological syndrome.

Authors:  J Klepper; D Wang; J Fischbarg; J C Vera; I T Jarjour; K R O'Driscoll; D C De Vivo
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  Expression of human glucose transporters in Xenopus oocytes: kinetic characterization and substrate specificities of the erythrocyte, liver, and brain isoforms.

Authors:  G W Gould; H M Thomas; T J Jess; G I Bell
Journal:  Biochemistry       Date:  1991-05-28       Impact factor: 3.162

3.  Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene.

Authors:  L Rossetti; A E Stenbit; W Chen; M Hu; N Barzilai; E B Katz; M J Charron
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 4.  The metabolic consequences of altered glucose transporter expression in transgenic mice.

Authors:  E B Katz; R Burcelin; T S Tsao; A E Stenbit; M J Charron
Journal:  J Mol Med (Berl)       Date:  1996-11       Impact factor: 4.599

5.  Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease.

Authors:  I A Simpson; K R Chundu; T Davies-Hill; W G Honer; P Davies
Journal:  Ann Neurol       Date:  1994-05       Impact factor: 10.422

Review 6.  Structure, function, and regulation of the mammalian facilitative glucose transporter gene family.

Authors:  A L Olson; J E Pessin
Journal:  Annu Rev Nutr       Date:  1996       Impact factor: 11.848

Review 7.  Fanconi-Bickel syndrome--the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature.

Authors:  R Santer; R Schneppenheim; D Suter; J Schaub; B Steinmann
Journal:  Eur J Pediatr       Date:  1998-10       Impact factor: 3.183

8.  Cellular localization and characterization of Glut 3 glucose transporter isoform in human brain.

Authors:  G J Mantych; D E James; H D Chung; S U Devaskar
Journal:  Endocrinology       Date:  1992-09       Impact factor: 4.736

9.  Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4.

Authors:  E B Katz; A E Stenbit; K Hatton; R DePinho; M J Charron
Journal:  Nature       Date:  1995-09-14       Impact factor: 49.962

10.  Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site.

Authors:  K Suzuki; T Kono
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

View more
  41 in total

Review 1.  Genetic hypoglycaemia in infancy and childhood: pathophysiology and diagnosis.

Authors:  J M Saudubray; P de Lonlay; G Touati; D Martin; M C Nassogne; P Castelnau; C Sevin; C Laborde; C Baussan; M Brivet; A Vassault; D Rabier; J P Bonnefont; P Kamoun
Journal:  J Inherit Metab Dis       Date:  2000-05       Impact factor: 4.982

2.  SLC2A2 mutations can cause neonatal diabetes, suggesting GLUT2 may have a role in human insulin secretion.

Authors:  F H Sansbury; S E Flanagan; J A L Houghton; F L Shuixian Shen; A M S Al-Senani; A M Habeb; M Abdullah; A Kariminejad; S Ellard; A T Hattersley
Journal:  Diabetologia       Date:  2012-06-02       Impact factor: 10.122

Review 3.  SGLT2 inhibition--a novel strategy for diabetes treatment.

Authors:  Edward C Chao; Robert R Henry
Journal:  Nat Rev Drug Discov       Date:  2010-05-28       Impact factor: 84.694

4.  Chronic stress modulates regional cerebral glucose transporter expression in an age-specific and sexually-dimorphic manner.

Authors:  Sean D Kelly; Constance S Harrell; Gretchen N Neigh
Journal:  Physiol Behav       Date:  2013-12-29

Review 5.  Physiology of cholangiocytes.

Authors:  James H Tabibian; Anatoliy I Masyuk; Tetyana V Masyuk; Steven P O'Hara; Nicholas F LaRusso
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

6.  A secondary respiratory chain defect in a patient with Fanconi-Bickel syndrome.

Authors:  M H Odièvre; A Lombès; P Dessemme; R Santer; M Brivet; B Chevallier; B Lagardère; M Odièvre
Journal:  J Inherit Metab Dis       Date:  2002-09       Impact factor: 4.982

Review 7.  Relevance of solute carrier family 5 transporter defects to inherited and acquired human disease.

Authors:  Miryam Cannizzaro; Jana Jarošová; Boel De Paepe
Journal:  J Appl Genet       Date:  2019-07-08       Impact factor: 3.240

8.  The HMGA1-IGF-I/IGFBP system: a novel pathway for modulating glucose uptake.

Authors:  Stefania Iiritano; Eusebio Chiefari; Valeria Ventura; Biagio Arcidiacono; Katiuscia Possidente; Aurora Nocera; Maria T Nevolo; Monica Fedele; Adelaide Greco; Manfredi Greco; Giuseppe Brunetti; Alfredo Fusco; Daniela Foti; Antonio Brunetti
Journal:  Mol Endocrinol       Date:  2012-06-28

Review 9.  On the free energy that drove primordial anabolism.

Authors:  Michael Kaufmann
Journal:  Int J Mol Sci       Date:  2009-04-22       Impact factor: 6.208

10.  A study of dapagliflozin in patients with type 2 diabetes receiving high doses of insulin plus insulin sensitizers: applicability of a novel insulin-independent treatment.

Authors:  John P H Wilding; Paul Norwood; Caroline T'joen; Arnaud Bastien; James F List; Fred T Fiedorek
Journal:  Diabetes Care       Date:  2009-06-15       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.